Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
1.500
+0.010 (0.67%)
At close: Aug 21, 2026, 4:00 PM EDT
1.520
+0.020 (1.33%)
After-hours: Aug 21, 2026, 7:59 PM EDT
Microbot Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Microbot Medical stock has a consensus rating of "Strong Buy" and an average price target of $6.67. The average 1-year stock price forecast is 344.67% higher than the current stock price, while the lowest is $4.00 (+166.67%) and the highest is $12 (+700.00%).
Price Target: $6.67 (+344.67%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Microbot Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +700.00% | Aug 19, 2026 |
Unknown Analyst Lucid Capital No rating | Lucid Capital | Buy Initiates $4 | Buy | Initiates | $4 | +166.67% | Jun 3, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $5.5 | Buy | Reiterates | $5.5 | +266.67% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
1.60M
Revenue Next Year
8.80M
from 1.60M
Increased by 450.46%
EPS This Year
-0.31
from -0.29
EPS Next Year
-0.34
from -0.31
EPS and Forward PE are based on non-GAAP adjusted numbers.